Global Biosimilars Market

Global Biosimilars Market by Player, Region, Type, Application and Sales Channel

Global Biosimilars Market

Global Biosimilars Market by Player, Region, Type, Application and Sales Channel

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global Biosimilars market size is estimated to be $34.66 billion in 2024, and Market IntelliX analysts predict it will reach $128.8 billion by 2033, growing at a CAGR of 15.7% during the forecast period from 2025 to 2033.

The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Biosimilars market competitiveness, regional economic interdependencies, and supply chain reconfigurations.

Biosimilars are safe, effective, and highly similar versions of approved and authorized biologics. A biological drug is a large and complex protein produced from living cells through complex manufacturing processes.

The major players in the global Biosimilars market include Sandoz (Switzerland), Pfizer (US), Amgen (US), Celltrion Healthcare (Korea), Biocon (India), Dr. Reddy's Laboratories (India), Eli Lilly (US), Teva Pharmaceutical (Israel), Fresenius Kabi (Germany), STADA Arzneimittel (Germany), etc. In 2024, the global top 5 players together accounted for approximately xx% market share in terms of revenue.

Market Drivers & Opportunities:

Rising global demand for affordable alternatives to expensive biologic therapies.

Impending and ongoing patent expiry of blockbuster biologics.

Growing focus on advanced R&D operating models.

Market Restraints & Challenges:

Manufacturing complexities and high cost of biosimilars.

Intense competition and pricing pressure among market players.

Increased market competition between biosimilar manufacturers and originator biologic companies.

North America Biosimilars market size is estimated to increase from $xx million in 2024 to $xx million by 2033, growing at a CAGR of xx% during the forecast period of 2025 through 2033.

China Biosimilars market size is estimated to increase from $xx million in 2024 to $xx million by 2033, growing at a CAGR of xx% during the forecast period of 2025 through 2033.

Europe Biosimilars market size is estimated to increase from $xx million in 2024 to $xx million by 2033, growing at a CAGR of xx% during the forecast period of 2025 through 2033.

Leading Players of Biosimilars include:

Sandoz (Switzerland)

Pfizer (US)

Amgen (US)

Celltrion Healthcare (Korea)

Biocon (India)

Dr. Reddy's Laboratories (India)

Eli Lilly (US)

Teva Pharmaceutical (Israel)

Fresenius Kabi (Germany)

STADA Arzneimittel (Germany)

Boehringer Ingelheim (Germany)

Samsung Biologics (Korea)

Amneal Pharmaceuticals (US)

Coherus BioSciences (US)

Bio-Thera Solutions (China)

Aprogen (Korea)

Shanghai Henlius Biopharmaceuticals (China)

Market split by Type:

Monoclonal Antibodies

Human Growth Hormone

Erythropoietin

Insulin

Granulocyte-Colony Stimulating Factor

Others

Market split by Application:

Blood Disorders

Oncology Diseases

Chronic & Autoimmune Diseases

Others

Market split by Sales Channel:

Direct Channel

Distribution Channel

Market split by Region/Country:

North America (United States and Canada)

Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia, etc.)

South America (Brazil, Mexico, and Argentina, etc.)

Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Chapter 1 Biosimilars Market Overview

1.1 Biosimilars Definition

1.2 Global Biosimilars Market Size Status and Outlook (2019-2033)

1.3 Global Biosimilars Market Size Comparison by Region (2019-2033)

1.4 Global Biosimilars Market Size Comparison by Type (2019-2033)

1.5 Global Biosimilars Market Size Comparison by Application (2019-2033)

1.6 Global Biosimilars Market Size Comparison by Sales Channel (2019-2033)

1.7 Biosimilars Market Dynamics (2025 US Tariffs Impacts)

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Restraints

1.7.3 Market News (Merger/Acquisition/Expansion)

1.7.4 Market Trends & Development

1.7.5 2025 US Tariffs Policy Impacts

Chapter 2 Biosimilars Market Competition by Player

2.1 Global Biosimilars Sales and Market Share by Player (2022-2024)

2.2 Global Biosimilars Revenue and Market Share by Player (2022-2024)

2.3 Global Biosimilars Average Price by Player (2022-2024)

2.4 Players Competition Situation & Trends

2.5 Conclusion of Competition by Player

Chapter 3 Biosimilars Market Segment by Type

3.1 Global Biosimilars Market by Type

3.1.1 Monoclonal Antibodies

3.1.2 Human Growth Hormone

3.1.3 Erythropoietin

3.1.4 Insulin

3.1.5 Granulocyte-Colony Stimulating Factor

3.2 Global Biosimilars Sales and Market Share by Type (2019-2024)

3.3 Global Biosimilars Revenue and Market Share by Type (2019-2024)

3.4 Global Biosimilars Average Price by Type (2019-2024)

3.5 Conclusion of Segment by Type

Chapter 4 Biosimilars Market Segment by Application

4.1 Global Biosimilars Market by Application

4.1.1 Blood Disorders

4.1.2 Oncology Diseases

4.1.3 Chronic & Autoimmune Diseases

4.1.4 Others

4.2 Global Biosimilars Revenue and Market Share by Application (2019-2024)

4.3 Conclusion of Segment by Application

Chapter 5 Biosimilars Market Segment by Sales Channel

5.1 Global Biosimilars Market by Sales Channel

5.1.1 Direct Channel

5.1.2 Distribution Channel

5.2 Global Biosimilars Revenue and Market Share by Sales Channel (2019-2024)

5.3 Conclusion of Segment by Sales Channel

Chapter 6 Biosimilars Market Segment by Region & Country

6.1 Global Biosimilars Market Size and CAGR by Region

6.2 Global Biosimilars Sales and Market Share by Region (2019-2024)

6.3 Global Biosimilars Revenue and Market Share by Region (2019-2024)

6.4 North America

6.4.1 North America Market by Country

6.4.2 North America Biosimilars Market Share by Type

6.4.3 North America Biosimilars Market Share by Application

6.4.4 United States

6.4.5 Canada

6.5 Europe

6.5.1 Europe Market by Country

6.5.2 Europe Biosimilars Market Share by Type

6.5.3 Europe Biosimilars Market Share by Application

6.5.4 Germany

6.5.5 UK

6.5.6 France

6.5.7 Italy

6.5.8 Spain

6.5.9 Russia

6.6 Asia-Pacific

6.6.1 Asia-Pacific Market by Country

6.6.2 Asia-Pacific Biosimilars Market Share by Type

6.6.3 Asia-Pacific Biosimilars Market Share by Application

6.6.4 China

6.6.5 Japan

6.6.6 Korea

6.6.7 India

6.6.8 Southeast Asia

6.6.9 Australia

6.7 South America

6.7.1 South America Market by Country

6.7.2 South America Biosimilars Market Share by Type

6.7.3 South America Biosimilars Market Share by Application

6.7.4 Brazil

6.7.5 Mexico

6.7.6 Argentina

6.7.7 Colombia

6.8 Middle East & Africa

6.8.1 Middle East & Africa Market by Country

6.8.2 Middle East & Africa Biosimilars Market Share by Type

6.8.3 Middle East & Africa Biosimilars Market Share by Application

6.8.4 Turkey

6.8.5 UAE

6.8.6 Saudi Arabia

6.8.7 South Africa

6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading Biosimilars Players

7.1 Sandoz (Switzerland)

7.1.1 Company Snapshot

7.1.2 Product/Service Offered

7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

7.1.4 Company News & Recent Development

7.1.5 Company SWOT Analysis

7.3 Amgen (US)

7.4 Celltrion Healthcare (Korea)

7.5 Biocon (India)

7.6 Dr. Reddy's Laboratories (India)

7.7 Eli Lilly (US)

7.8 Teva Pharmaceutical (Israel)

7.9 Fresenius Kabi (Germany)

7.10 STADA Arzneimittel (Germany)

7.11 Boehringer Ingelheim (Germany)

7.12 Samsung Biologics (Korea)

7.13 Amneal Pharmaceuticals (US)

7.14 Coherus BioSciences (US)

7.15 Bio-Thera Solutions (China)

7.16 Aprogen (Korea)

7.17 Shanghai Henlius Biopharmaceuticals (China)

Chapter 8 Upstream and Downstream Analysis of Biosimilars

8.1 Industrial Value Chain of Biosimilars

8.2 Upstream of Biosimilars

8.3 Downstream of Biosimilars

Chapter 9 Global Biosimilars Market Forecast (2025-2033)

9.1 Global Biosimilars Market Size (Sales and Revenue) Forecast (2025-2033)

9.2 Global Biosimilars Market Size and CAGR Forecast by Region (2025-2033)

9.3 Global Biosimilars Market Size and CAGR Forecast by Type (2025-2033)

9.4 Global Biosimilars Market Size and CAGR Forecast by Application (2025-2033)

9.5 Global Biosimilars Market Size and CAGR Forecast by Sales Channel (2025-2033)

Chapter 10 Appendix

10.1 Research Methodology

10.2 Data Sources

10.3 Disclaimer

10.4 Analysts Certification

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global Biosimilars Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What is the forecasted growth rate of the Global Biosimilars Market?
The Global Biosimilars Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
What trends may have an impact on the Global Biosimilars Market's growth?
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global Biosimilars Market as well as its distribution among its players
How is the competitive landscape for the Global Biosimilars Market defined?
Companies in the Global Biosimilars Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Biosimilars Market's trajectory and future outlook.